Polymer Nanoformulation of Sorafenib and All-Trans Retinoic Acid for Synergistic Inhibition of Thyroid Cancer
Part of differentiated thyroid cancer will relapse or develop into dedifferentiated thyroid cancer after standard therapy, such as surgery or radionuclide therapy. Sorafenib (SOR) is recommended for the treatment of advanced or radioiodine-refractory thyroid cancer. The monotherapy using SOR is ofte...
Saved in:
Main Authors: | Shijie Li (Author), Shujun Dong (Author), Weiguo Xu (Author), Yang Jiang (Author), Zhongmin Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of All-Trans Retinoic Acid Supplementation to Periodontitis
by: Praptiwi Hanafi, et al.
Published: (2015) -
All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia
by: Yan Chen, et al.
Published: (2024) -
Transient abnormal megakaryocytic hyperplasia secondary to all-trans retinoic acid therapy
by: Monica Jain, et al.
Published: (2012) -
The Antagonist of Retinoic Acid Receptor α, ER-50891 Antagonizes the Inhibitive Effect of All-Trans Retinoic Acid and Rescues Bone Morphogenetic Protein 2-Induced Osteoblastogenic Differentiation
by: Wang S, et al.
Published: (2020) -
Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011)